Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Human CD171/L1CAM Protein, C-His

Catalog #:   EHD98202 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian Cells
Accession: P32004
Protein length: Met1-Glu1120
Overview

Catalog No.

EHD98202

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

Met1-Glu1120

Predicted molecular weight

126.32 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P32004

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Neural cell adhesion molecule L1, N-CAM-L1, NCAM-L1, CD171, L1CAM, CAML1, MIC5

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human CD171/L1CAM protein
References

Characterization of tRNA-derived fragments in the small neuron-derived extracellular vesicles of Alzheimer's disease patients., PMID:40436234

In Vitro and In Vivo Studies of Melanoma Cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM., PMID:38732030

Label-Free Multiplex Profiling of Exosomal Proteins with a Deep Learning-Driven 3D Surround-Enhancing SERS Platform for Early Cancer Diagnosis., PMID:38624007

Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis., PMID:38145160

Vesicular HMGB1 release from neurons stressed with spreading depolarization enables confined inflammatory signaling to astrocytes., PMID:38082296

Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization., PMID:37749499

Interaction of L1CAM with LC3 Is Required for L1-Dependent Neurite Outgrowth and Neuronal Survival., PMID:37569906

Magnetic Separation of Cell-Secreted Vesicles with Tailored Magnetic Particles and Downstream Applications., PMID:37140802

Targeted surface marker screening on neuronal structures in the human choroid., PMID:36586549

Abnormal levels of mitochondrial Ca2+ channel proteins in plasma neuron-derived extracellular vesicles of early schizophrenia., PMID:35867070

β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis., PMID:35550625

L1CAM-associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization., PMID:35492832

Antagonistic L1 Adhesion Molecule Mimetic Compounds Inhibit Glioblastoma Cell Migration In Vitro., PMID:35327631

Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy., PMID:35075190

Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury., PMID:34678224

Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids., PMID:33897875

Chimeric antigen receptor T cell therapy in oncology - Pipeline at a glance: Analysis of the ClinicalTrials.gov database., PMID:33497760

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma., PMID:33082316

Extracellular Vesicles of Alzheimer's Disease Patients as a Biomarker for Disease Progression., PMID:32676990

Expression and function of voltage gated proton channels (Hv1) in MDA-MB-231 cells., PMID:32374759

Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy., PMID:32296437

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing., PMID:31500597

Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness., PMID:31426278

Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion., PMID:30315942

Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors., PMID:30235708

Temporal expression of CD184(CXCR4) and CD171(L1CAM) identifies distinct early developmental stages of human retinal ganglion cells in embryonic stem cell derived retina., PMID:27867005

Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors., PMID:27419370

Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility., PMID:27390347

Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer., PMID:27343445

Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells., PMID:27091730

Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation., PMID:26883759

Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes., PMID:26497209

L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression., PMID:24746181

Diverse solid tumors expressing a restricted epitope of L1-CAM can be targeted by chimeric antigen receptor redirected T lymphocytes., PMID:24509172

[Research development of L1-CAM(CD171)in human cancer]., PMID:24246931

The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors., PMID:24166603

Cell recognition molecule L1 promotes embryonic stem cell differentiation through the regulation of cell surface glycosylation., PMID:24070611

L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor., PMID:23212305

Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma., PMID:22210381

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients., PMID:21600041

L1 stimulation of human glioma cell motility correlates with FAK activation., PMID:21373966

L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1., PMID:21297581

L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues., PMID:21195422

DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours., PMID:20716168

Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma., PMID:20215505

Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion., PMID:19893036

Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule., PMID:19874583

Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer., PMID:19435915

Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma., PMID:19414364

alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma., PMID:19082495

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CD171/L1CAM Protein, C-His [EHD98202]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only